Michael E. Castagna, PharmD

2018

In 2018, Michael E. Castagna, PharmD earned a total compensation of $1.5M as Chief Executive Officer at MannKind, a 13% increase compared to previous year.

Compensation breakdown

Bonus$20,000
Non-Equity Incentive Plan$150,000
Option Awards$833,040
Salary$500,000
Other$5,701
Total$1,508,741

PharmD received $833K in option awards, accounting for 55% of the total pay in 2018.

PharmD also received $20K in bonus, $150K in non-equity incentive plan, $500K in salary and $5.7K in other compensation.

Rankings

In 2018, Michael E. Castagna, PharmD's compensation ranked 7,132nd out of 14,244 executives tracked by ExecPay. In other words, PharmD earned more than 49.9% of executives.

ClassificationRankingPercentile
All
7,132
out of 14,244
50th
Division
Manufacturing
2,748
out of 5,759
52nd
Major group
Chemicals And Allied Products
1,036
out of 2,122
51st
Industry group
Drugs
875
out of 1,811
52nd
Industry
Pharmaceutical Preparations
683
out of 1,385
51st

Pay ratio

Michael E. Castagna, PharmD's Pay$1,508,741
Median Employee's Pay$143,562
Pay Ratio

to 1

In 2018, the annual total compensation of Michael E. Castagna, PharmD was $1,508,741.

The annual total compensation of the median employee at MannKind was $143,562.

The ratio of Michael E. Castagna, PharmD's pay to the pay of median employee was therefore to one.

Source: SEC filing on April 10, 2020.

PharmD's colleagues

We found five more compensation records of executives who worked with Michael E. Castagna, PharmD at MannKind in 2018.

2018

Michael Castagna

MannKind

Chief Executive Officer

2018

David Kendall

MannKind

Chief Medical Officer

2018

James McCauley

MannKind

Chief Commercial Officer

2018

David Thomson

MannKind

General Counsel

2018

Steven Binder

MannKind

Chief Financial Officer

News

In-depth

You may also like